Vaccines MarketThe global vaccines market is on a robust growth trajectory, projected to rise from USD 42.7 billion in 2023 ...
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
Zacks.com on MSN4d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine MenveoGSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
PA Media on MSN4d
UK ‘on the brink of defeating’ meningitis CThere were just three cases of meningococcal group C – the infection which can lead to meningitis C – last year, the UK ...
The European Commission (EC) has granted approval for a single-vial, fully liquid presentation of GSK's Menveo vaccine ...
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
Head of Global Vaccines Research & Development Philip Dormitzer said: "As a leader in meningococcal vaccines, GSK is dedicated to finding innovative solutions that simplify immunisation and support ...
GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...
GSK's liquid meningitis vaccine, Menveo, received approval from the European ... fully liquid vaccine supports simplifying the vaccination process against invasive meningococcal disease, or IMD, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback